Evaluation and appraisal of randomized controlled trials in myeloma

Annals of Oncology

Volumn 12, Issue 11, 2001, Pages 1611-1617

  Djulbegovic, B ^a   Adams, J R ^b   Lyman, G H ^c   Lacevic, M ^a   Hozo, I ^d   Greenwich, M ^e   Bennett, C L ^b,f  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d INDIANA UNIVERSITY NORTHWEST   (United States)

^e PURDUE UNIVERSITY CALUMET   (United States)

^f Lakeside VA   (United States)

Author keywords

Critical appraisal; Evidence based medicine; Innovationsw; Multiple myeloma; Quality assessment; Randomized trials

Indexed keywords

ARTICLE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; EXPERIMENTAL DESIGN; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MULTIPLE MYELOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 0035695599     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013181331874     Document Type: Article

References (38)

1. 7The Quality of the Medical Evidence: Is it good enough?
2. Manuscript quality before and after peer review and editing
3. Empirical-evidence of bias-dimensions of methodological quality associated with estimates of treatment effects in controlled trials
4. How study design affects outcomes in comparison of therapy
5. Dissemination of medical information: A journal's role
6. The Science of Reviewing Research
7. Evaluation of conflict of interest in economic analyses of new drugs used in oncology
8. Violation of the Uncertainty Principle in Conduct of Randomized Controlled Trials (RCTs) of Erythropoietin (EPO)
9. The uncertainty principle and industry-sponsored research
10. Identifying relevant studies for systemic reviews
11. The quality of medical evidence in hematology-oncology
12. Bias in the analyses and reporting of randomized controlled trials
13. Assessing the quality of randomized controlled trials
14. Assessing the quality of reports of randomized trials: Implications for the conduct of meta-analyses
15. Evidence based medicine in LIVER
16. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: Introduction and design
17. What is meant by intention to treat analysis? Survey of published controlled trials
18. Statistical power, sample size, and their reporting in randomized controlled trials
19. Influences on the quality of published drug studies
20. Journal citation reports: Bibliometric analysis of science journals on the first database
21. Fortnightly review: How can impact factors be improved?
22. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
23. An assessment of clinically useful measures of the consequences of treatment
24. Evidence-Based Medicine
25. Level of evidence and grades of recommendations
26. Randomized Controlled Trials
27. Improving the quality of reporting of randomized controlled trials: The CONSORT statement
28. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
29. The revised CONSORT statement: Explanation and elaboration
30. A Difficult Balance: Editorial Peer Review in Medicine
31. Quality of full and final publications reporting acutestroke trials: A systematic review
32. 'Negative trials' are positive
33. The existence of publication bias and risk factors for its occurrence